Overview
Mark Roh is a Surgical Oncologist practicing medicine in Orlando, Florida.
His clinical expertise encompasses Gallbladder Adenocarcinoma, Gallbladder Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Liposarcoma.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 S Orange Ave, Orlando, FL 32806
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Orlando Health Cancer Institute - Downtown Orlando
Juan Pablo Arnoletti, MD, is a board-certified surgical oncologist with the Orlando Health Cancer Institute. He specializes in treating cancers of the gastrointestinal tract, which is comprised of the liver, pancreas, bile ducts and stomach, and has a particular interest in soft tissue sarcoma, spleen disorders and adrenal tumors.As a student in Montevideo, Uruguay, Dr. Arnoletti earned a bachelor’s degree in biological sciences from Crandon Institute and medical degree from the University of the Republic Medical School. He began his postdoctoral studies in Philadelphia as a research fellow in the department of surgery at the Medical College of Pennsylvania and MCP-Hahnemann University. He remained at MCP-Hahnemann for his residency in general surgery and then went onto Fox Chase Cancer Center, also in Philadelphia, for a fellowship in surgical oncology.Dr. Arnoletti is certified by the American Board of Surgery and a fellow of the American College of Surgeons. He is a member of many professional organizations, including the Society of Surgical Oncology; Society for Surgery of the Alimentary Tract; American Society of Clinical Oncology; Association for Academic Surgery; American Association for Cancer Research; American Hepato-Pancreato-Biliary Association; and Society of University Surgeons.Dr. Arnoletti has held leadership and academic roles throughout his career, most recently as a professor of surgery at the University of Central Florida College Medicine and Florida State University School of Medicine in Tallahassee. He also has been recognized as one of Orlando Magazine’s Best Doctors in America every year since 2012. Dr. Arnoletti is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Splenectomy.
AdventHealth Medical Group Breast Surgery At Winter Park
Kamy Kemp is a Surgical Oncologist practicing medicine in Winter Park, Florida. Dr. Kemp is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Intraductal Papilloma, and Angiosarcoma. Dr. Kemp is currently accepting new patients.
Edwin M Villalobos MD PA
Lisa Minton is a Surgical Oncologist practicing medicine in Altamonte Springs, Florida. Dr. Minton is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy.
Frequently Asked Questions about Dr. Mark Roh
How do I make an appointment with Dr. Mark Roh?
You can book an appointment with Dr. Mark Roh by calling their office at 407-648-3800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Roh a top-rated expert for Gallbladder Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Roh is classified as an Experienced expert for Gallbladder Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Roh specialize in?
While Dr. Mark Roh is a Surgical Oncology, they have specific expertise in Gallbladder Adenocarcinoma, Gallbladder Cancer, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.
Does Dr. Mark Roh participate in research or clinical trials?
Yes. Dr. Mark Roh has published 11 articles and abstracts on conditions like Gallbladder Adenocarcinoma. You can view a list of Dr. Mark Roh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Roh accept my insurance?
Dr. Mark Roh accepts most major insurance plans, including Meridian Choice. We recommend calling the office directly at 407-648-3800 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorDr. Roh isExperienced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Roh isExperienced. Learn about Epithelioid Sarcoma.
- Fibrolamellar CarcinomaDr. Roh isExperienced. Learn about Fibrolamellar Carcinoma.
- FibrosarcomaDr. Roh isExperienced. Learn about Fibrosarcoma.
- Gallbladder AdenocarcinomaDr. Roh isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Roh isExperienced. Learn about Gallbladder Cancer.
